Skip to content

Feasibility Study: Comparison of Performance Status With Objective Physical Activity Monitors

OS09328 Feasibility Study: Comparison of Performance Status With Objective Physical Activity Monitors

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01063400
Enrollment
6
Registered
2010-02-05
Start date
2010-01-31
Completion date
2011-09-30
Last updated
2012-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Small Cell Lung Cancer

Brief summary

The purpose of this research is to examine the relationship between performance status rating and the actual amount of physical activity a subject does when it is measured by an activity monitor.

Interventions

OTHERObservation

monitoring of physical activity for 14 days using physical activity monitoring devices along with activity diary

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Worst Daily Pain rating of \< 4/10 * ECOG Performance Status of 0, 1, or 2 * Prior malignancy is allowed as long as it is inactive or well-controlled without current anti-tumor therapy required

Exclusion criteria

* Known brain metastasis * Use of assistive devices (cane, crutch) * No concurrent radiotherapy: all radiotherapy must be completed 4 weeks prior to enrollment in this study * Patients receiving only targeted therapy are not eligible(e.g.erlotinib)

Design outcomes

Primary

MeasureTime frame
To determine the feasibility of examining physical activity (through objective measurement devices) and performance status in a 14-day study of lung cancer patients.14 days

Secondary

MeasureTime frame
To determine the number of days of monitoring necessary to reliably estimate energy expenditure (steps/day, and % of time spent sedentary) in lung cancer patients undergoing chemotherapy.14 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026